Update shared on09 Oct 2025
Fair value Increased 1.60%Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions.
Analyst Commentary
Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity. Analysts continue to adjust their estimates and perspectives based on shifting fundamentals, key portfolio transactions, and evolving market dynamics in the global fertilizer sector.
Bullish Takeaways
- Some bullish analysts have raised their price targets for Nutrien, driven by improving pricing trends in fertilizer markets and more resilient than expected demand, particularly for nitrogen and potash products.
- Upgrades highlight a preference for fertilizer companies over petrochemical peers given tight supply and demand dynamics, low inventory levels, and a more constructive multi-year outlook for the sector.
- Recent asset sales by Nutrien are seen as positive because they allow the company to streamline its portfolio and focus capital on core operations, potentially supporting longer-term valuations.
- Fertilizer stocks, including Nutrien, are viewed as a defensive sector that can benefit from market volatility and geopolitical disruptions, with limited direct tariff impacts and a degree of insulation from global macro uncertainty.
Bearish Takeaways
- Bearish analysts have trimmed price targets based on expected medium-term declines in NPK (nitrogen, phosphate, and potash) fertilizer pricing, which could limit top-line growth and pressure margins as new capacity comes online.
- The recent sale of stakes in certain assets may reduce near-term earnings contributions, tempering the upside from portfolio optimization efforts.
- Concerns remain that much of Nutrien’s positive earnings momentum is already priced into the shares and that consensus estimates could peak in the coming years, particularly by mid-2026.
- Risks highlighted for 2027 include heightened market sensitivity to supply shocks and the potential for margin pressure, especially in nitrogen products, which may dampen growth prospects down the road.
What's in the News
- The U.S. Department of Agriculture and Department of Justice have initiated an antitrust investigation into crop input suppliers, including fertilizer firms such as Nutrien. The investigation aims to scrutinize competitive conditions in the agriculture marketplace (Bloomberg).
- Nutrien revised its operating guidance for fiscal year 2025 and increased projected potash sales volumes to a range of 13.9 million to 14.5 million tonnes compared to earlier guidance.
- The company has completed the repurchase of 5.7 million shares, representing 1.17% of its total shares outstanding, under the buyback program announced in February 2025. The total value of the repurchase is CAD 311.19 million.
Valuation Changes
- Fair Value Estimate has risen slightly from CA$86.17 to CA$87.54. This reflects an updated assessment of Nutrien's long-term prospects.
- Discount Rate has increased marginally from 7.22% to 7.25%. This indicates a modest adjustment to risk and return expectations.
- Revenue Growth Projection is up slightly from 3.25% to 3.26%. This signals a modestly improved outlook for future sales expansion.
- Net Profit Margin has edged down moderately from 8.52% to 8.52%. This suggests stable but slightly compressed profitability expectations.
- Future P/E Ratio estimate is largely unchanged, ticking up from 15.18x to 15.19x. This implies analysts see little change in market valuation multiples for Nutrien going forward.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.